CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 53 filers reported holding CASI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $288,000 | +8.3% | 355,552 | +7.0% | 0.00% | – |
| Q4 2021 | $266,000 | -32.7% | 332,142 | 0.0% | 0.00% | – |
| Q3 2021 | $395,000 | +30.8% | 332,142 | +70.5% | 0.00% | – |
| Q2 2021 | $302,000 | -87.9% | 194,842 | -81.3% | 0.00% | – |
| Q1 2021 | $2,495,000 | -21.2% | 1,039,742 | -3.2% | 0.00% | – |
| Q4 2020 | $3,168,000 | +103.5% | 1,074,024 | +5.5% | 0.00% | – |
| Q3 2020 | $1,557,000 | -34.8% | 1,017,612 | +6.5% | 0.00% | – |
| Q2 2020 | $2,388,000 | +28.9% | 955,232 | +5.2% | 0.00% | – |
| Q1 2020 | $1,852,000 | -37.0% | 907,963 | -4.6% | 0.00% | – |
| Q4 2019 | $2,940,000 | +0.6% | 951,326 | +8.7% | 0.00% | – |
| Q3 2019 | $2,923,000 | +4.9% | 875,142 | +0.5% | 0.00% | – |
| Q2 2019 | $2,786,000 | +22.1% | 870,778 | +9.5% | 0.00% | – |
| Q1 2019 | $2,282,000 | -25.9% | 795,175 | +3.8% | 0.00% | – |
| Q4 2018 | $3,081,000 | -15.8% | 766,307 | -2.2% | 0.00% | – |
| Q3 2018 | $3,657,000 | -25.1% | 783,168 | +32.0% | 0.00% | – |
| Q2 2018 | $4,880,000 | +4829.3% | 593,163 | +2410.3% | 0.00% | – |
| Q1 2018 | $99,000 | – | 23,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $19,934,000 | 16.36% |
| Wellington Shields & Co., LLC | 1,585,609 | $3,964,000 | 1.74% |
| Wellington Shields Capital Management, LLC | 1,321,745 | $3,304,000 | 0.53% |
| Ikarian Capital, LLC | 1,039,910 | $2,600,000 | 0.21% |
| Zebra Capital Management LLC | 50,658 | $127,000 | 0.18% |
| BOOTHBAY FUND MANAGEMENT, LLC | 139,183 | $348,000 | 0.02% |
| Manatuck Hill Partners, LLC | 15,090 | $38,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 205,200 | $513,000 | 0.01% |
| IHT Wealth Management, LLC | 26,000 | $65,000 | 0.01% |
| Vident Investment Advisory, LLC | 67,540 | $169,000 | 0.01% |